Activating mutations in the NF-κB, Notch, JAK/STAT3, RHOA, and PI3K/AKT signaling pathways have been found to play crucial roles in the pathogenesis of PTCL. Here, NFKB1 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.